Altshuler Shaham’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-153
| Closed | -$20.2K | – | 332 |
|
|
2023
Q4 | $20.2K | Sell |
153
-55
| -26% | -$7.25K | ﹤0.01% | 190 |
|
|
2023
Q3 | $23.4K | Buy |
+208
| New | +$23.4K | ﹤0.01% | 206 |
|
|
2023
Q1 | – | Sell |
-500
| Closed | -$59.7K | – | 427 |
|
|
2022
Q4 | $59.7K | Sell |
500
-71
| -12% | -$8.48K | ﹤0.01% | 184 |
|
|
2022
Q3 | $59K | Sell |
571
-143
| -20% | -$14.8K | ﹤0.01% | 192 |
|
|
2022
Q2 | $70K | Buy |
714
+279
| +64% | +$27.4K | ﹤0.01% | 187 |
|
|
2022
Q1 | $41K | Buy |
+435
| New | +$41K | ﹤0.01% | 388 |
|
|
2020
Q4 | – | Sell |
-646
| Closed | -$62K | – | 435 |
|
|
2020
Q3 | $62K | Buy |
646
+179
| +38% | +$17.2K | ﹤0.01% | 205 |
|
|
2020
Q2 | $57K | Buy |
+467
| New | +$57K | ﹤0.01% | 184 |
|
|
2020
Q1 | – | Sell |
-262
| Closed | -$28K | – | 559 |
|
|
2019
Q4 | $28K | Buy |
262
+166
| +173% | +$17.7K | ﹤0.01% | 229 |
|
|
2019
Q3 | $9K | Buy |
+96
| New | +$9K | ﹤0.01% | 304 |
|